ThyroidAmerican Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum

✅ Guideline Update

The 2026 ATA guidelines, endorsed by 12 international societies, revise diagnosis and management of thyroid dysfunction across the reproductive continuum. Key updates reflect three large randomized trials published since 2017 and reframe LT4 treatment indications for subclinical hypothyroidism and TPOAb-positive women.

Clinical Considerations

• LT4 is no longer indicated for euthyroid TPOAb-positive women with infertility or recurrent miscarriage; three high-quality RCTs showed no improvement in fertility or pregnancy outcomes regardless of TSH concentration or prior miscarriage history
• For subclinical hypothyroidism, confirmatory repeat TSH/fT4 testing after 4–6 weeks is now recommended before initiating LT4, as abnormal values normalize spontaneously in up to 80% of mild cases; immediate treatment is reasonable when TSH exceeds 6 mU/L or TPOAb positivity is confirmed
• Mild overt hypothyroidism (TSH above pregnancy upper limit but below 6 mU/L) may be reassessed before treatment, as fewer than half of untreated cases persist on recheck within 1–3 weeks
• ATD selection in pregnancy: PTU is preferred over MMI in the first trimester when continuation is necessary; absolute risk of congenital malformations increases by 8.8/1,000 live births with PTU vs. 17.1/1,000 with MMI alone

Practice Applications

• Recognize that TPOAb positivity in euthyroid patients reflects autoimmune susceptibility, not a treatment target; monitor TSH every 3–6 months preconception
• Monitor women with subclinical hypothyroidism confirmed in the first trimester through shared decision-making on LT4 initiation, with repeat thyroid function within 3 weeks if treatment deferred
• Consider switching women on liothyronine or desiccated thyroid to LT4 monotherapy before conception to protect fetal central nervous system thyroid hormone availability
• Integrate trimester- and laboratory-specific TSH reference intervals where available; in their absence, apply a first-trimester upper limit of approximately 4.0 mU/L